Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for DNA

Stock NameGinkgo Bioworks Holdings
TickerDNA(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS37611X1000

Show aggregate DNA holdings

News associated with DNA

Ginkgo Bioworks (NYSE:DNA) Price Target Raised to $9.00
Ginkgo Bioworks (NYSE:DNA – Free Report) had its target price lifted by BTIG Research from $6.00 to $9.00 in a report issued on Monday morning,Benzinga reports. The firm currently has a sell rating on the stock. Separately, Cowen restated a “buy” rating on shares of Ginkgo Bioworks in a research report on Friday, August 8th. […] - 2025-08-26 02:54:46
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Purchased by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lifted its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 63.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 311,846 shares of the company’s stock after purchasing an additional 120,572 shares during the quarter. Exchange […] - 2025-06-18 05:18:50
Squarepoint Ops LLC Sells 60,696 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Squarepoint Ops LLC reduced its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 58.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 42,490 shares of the company’s stock after selling 60,696 shares during the period. Squarepoint Ops LLC’s holdings in Ginkgo Bioworks were worth $417,000 as of its […] - 2025-06-06 05:14:56
Millennium Management LLC Buys 523,571 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Millennium Management LLC increased its stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 357.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 670,065 shares of the company’s stock after acquiring an additional 523,571 shares during the quarter. Millennium Management LLC’s holdings in Ginkgo Bioworks were worth $6,580,000 at […] - 2025-05-28 04:56:51
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Bank of America Corp DE
Bank of America Corp DE grew its position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 780.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,764,455 shares of the company’s stock after acquiring an additional 3,336,964 shares during the period. Bank of […] - 2025-05-16 06:03:08
BNP Paribas Financial Markets Increases Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
BNP Paribas Financial Markets raised its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 80.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 285,111 shares of the company’s stock after buying an additional 127,249 shares during […] - 2025-05-16 05:24:57
Tower Research Capital LLC TRC Has $167,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Tower Research Capital LLC TRC lessened its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 18.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 16,972 shares of the company’s stock after selling 3,899 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Ginkgo Bioworks were worth $167,000 […] - 2025-05-07 05:32:53
Ginkgo Bioworks (NYSE:DNA) versus Palisade Bio (NASDAQ:PALI) Financial Contrast
Ginkgo Bioworks (NYSE:DNA – Get Free Report) and Palisade Bio (NASDAQ:PALI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a breakdown of […] - 2025-05-07 03:08:50
Marshall Wace LLP Makes New $665,000 Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Marshall Wace LLP purchased a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 67,684 shares of the company’s stock, valued at approximately $665,000. Marshall Wace LLP owned approximately 0.12% of Ginkgo […] - 2025-05-02 05:32:47
SBI Securities Co. Ltd. Purchases Shares of 2,905 Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
SBI Securities Co. Ltd. purchased a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,905 shares of the company’s stock, valued at approximately $29,000. Other institutional investors have also […] - 2025-03-13 06:02:49

iShares MSCI World Small Cap UCITS ETF USD (Acc) DNA holdings

DateNumber of DNA Shares HeldBase Market Value of DNA SharesLocal Market Value of DNA SharesChange in DNA Shares HeldChange in DNA Base ValueCurrent Price per DNA Share HeldPrevious Price per DNA Share Held
2025-10-15 (Wednesday)18,732USD 296,528USD 296,528
2025-10-10 (Friday)18,600USD 251,472USD 251,472
2025-10-08 (Wednesday)18,600USD 299,274USD 299,274
2025-10-07 (Tuesday)18,600DNA holding increased by 86USD 275,652DNA holding increased by 349USD 275,65286USD 349 USD 14.82 USD 14.87
2025-10-06 (Monday)18,514USD 275,303DNA holding decreased by -23513USD 275,3030USD -23,513 USD 14.87 USD 16.14
2025-10-03 (Friday)18,514USD 298,816DNA holding increased by 3147USD 298,8160USD 3,147 USD 16.14 USD 15.97
2025-10-02 (Thursday)18,514USD 295,669DNA holding increased by 24069USD 295,6690USD 24,069 USD 15.97 USD 14.67
2025-10-01 (Wednesday)18,514USD 271,600DNA holding increased by 1666USD 271,6000USD 1,666 USD 14.67 USD 14.58
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DNA by Blackrock for IE00BF4RFH31

Show aggregate share trades of DNA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-07BUY86 14.820* 9.21
2025-08-15BUY86 13.180* 8.96
2025-07-14BUY176 9.940* 8.83
2025-06-30BUY176 11.250* 8.71
2025-06-25BUY264 9.320* 8.70
2025-06-20SELL-44 8.570* 8.70 Profit of 383 on sale
2025-06-12SELL-352 9.290* 8.70 Profit of 3,061 on sale
2025-06-02BUY132 7.130* 8.74
2025-05-28BUY88 7.420* 8.78
2025-05-14BUY44 7.830* 8.88
2025-05-13BUY88 8.120* 8.89
2025-05-07BUY132 7.400* 8.92
2025-04-28BUY44 8.020* 9.03
2025-04-16BUY559 8.090* 9.13
2025-04-14BUY86 8.360* 9.14
2025-04-08SELL-86 5.760* 9.23 Profit of 794 on sale
2025-04-04SELL-86 5.570* 9.30 Profit of 799 on sale
2025-03-28BUY430 6.120* 9.44
2025-03-12SELL-86 6.650* 9.79 Profit of 842 on sale
2025-03-04SELL-86 8.120* 9.93 Profit of 854 on sale
2025-02-26SELL-172 9.110* 10.01 Profit of 1,721 on sale
2025-02-13BUY43 13.550* 9.66
2025-02-12BUY172 12.320* 9.62
2025-01-27BUY43 11.820* 8.72
2025-01-23BUY43 13.180* 8.55
2024-12-09BUY1,548 10.700* 8.25
2024-12-04BUY86 10.410* 8.08
2024-12-03BUY129 9.730* 8.04
2024-11-19BUY252 6.450* 8.15
2024-11-18BUY84 6.330* 8.21
2024-11-12BUY168 8.390* 8.20
2024-11-11BUY42 8.760* 8.18
2024-11-07BUY210 8.380* 8.14
2024-11-07BUY210 8.380* 8.14
2024-10-23BUY84 9.050* 9.15
2024-10-23BUY84 9.050* 9.15
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DNA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19311,3430688,14145.2%
2025-09-18237,0850571,98441.4%
2025-09-17390,999200809,16448.3%
2025-09-16244,2930433,04956.4%
2025-09-15238,6880607,26639.3%
2025-09-12389,6876,454759,53751.3%
2025-09-11560,5786,0471,250,18944.8%
2025-09-10466,6570912,67451.1%
2025-09-09304,200275706,98743.0%
2025-09-08351,35336,519736,11347.7%
2025-09-05566,90032,5431,066,27253.2%
2025-09-04354,0088,557645,68654.8%
2025-09-03512,95997,543941,94954.5%
2025-09-02987,971148,3781,789,85655.2%
2025-08-29671,37901,348,65649.8%
2025-08-28595,231101,102,03754.0%
2025-08-27492,6290862,15357.1%
2025-08-26520,624639893,41758.3%
2025-08-25396,1790674,04558.8%
2025-08-22579,3638151,073,71354.0%
2025-08-21337,469100579,22958.3%
2025-08-20379,84951,517759,42450.0%
2025-08-19540,73148,192893,26460.5%
2025-08-18547,4092,234895,37761.1%
2025-08-15373,48390594,50262.8%
2025-08-14363,655667715,12950.9%
2025-08-13562,44716,0441,084,19651.9%
2025-08-12291,6450627,06146.5%
2025-08-11313,55255,570672,61446.6%
2025-08-08442,74940,378963,76945.9%
2025-08-07439,4112,264892,11849.3%
2025-08-06365,8262,846613,80459.6%
2025-08-05583,8966,7391,015,18257.5%
2025-08-04493,55861,417827,60359.6%
2025-08-01345,96630,419582,73759.4%
2025-07-31348,579608624,30755.8%
2025-07-30428,49738,545719,10659.6%
2025-07-29337,9802,726695,11348.6%
2025-07-28270,36742,479496,68754.4%
2025-07-25345,44533,133650,89953.1%
2025-07-24733,1263431,480,19749.5%
2025-07-23435,6245161,213,18235.9%
2025-07-22964,9594,7571,585,12060.9%
2025-07-21773,5567531,215,60463.6%
2025-07-18372,6021,023615,48860.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.